Cue the $100 Roll
3M Co. (MMM) has been an incredible investment this year, increasing 30% while paying out a 2.5% annual dividend yield. The Post-It Note King could finally surpass the $100 share price before the end of the year.
Barron's put out a piece today titled 3M Can Post Further Gains. Thanks to today's news that 3M is going to pickup Ceradyne (CRDN) for about $860 million the company will be able to post further gains. Ceradyne means 3M will rake in more revenue in a number of industries, from energy to defense and transportation.
3M sports a P/E of 15 and its shares have been on a steady incline since summer. With the market trading sideways for the foreseeable future 3M looks attractive for a slow climb while paying out a dividend. Ceradyne could finally put 3M over the $100 price level.
Best of the Blogs
Scanning and identifying the best blog entries every hour
- OPEC Set To Pump Even More Oil In April As Saudi Arabia Boosts Exports To Near-Record High Levels | ZeroHedge
- Mega M&A Is Back: Abbott Buys St. Jude Medical For $25 Billion, 37% Premium | ZeroHedge
- Money Is Energy: George Mobus Discusses Biophysical Economics and Alternative Theories of Value | Financial Sense
- Hillary Will Be The Least Of Your Worries - America Has Economic Diarrhea | ZeroHedge
- America's Entitled (And Doomed) Upper Middle Class | ZeroHedge
- Gold More Productive Than Cash?! | ZeroHedge
- Trending On Twitter | ZeroHedge
The most relevant financial news and articles from the Internets
- An outbreak of a highly contagious disease is sweeping through Harvard | Business Insider
- DAVID CHANG: Here's why the restaurant industry is about to face an... | Business Insider
- 'You didn't know if he was in his pajamas': Fox News anchor '... | Business Insider
- Raucous protesters and supporters of Donald Trump violently... | Business Insider
- Step inside the cockpit of the US's most iconic war planes | Business Insider
- Stephen Colbert tries to cheer up Ted Cruz after an embarrassing speech gaffe | Business Insider
- Mark Zuckerberg thinks he has responsibility to help cure all diseases... | Business Insider